| BCBS Federal Medical & Drug | 5.85.023 Icatibant | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.85.032 Takhzyro (lanadelumab-flyo) | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.85.033 Ultomiris (ravulizumab-cwvz) | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.85.069 Xromi (hydroxyurea) | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.85.073 Wayrilz (rilzabrutinib) | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.90.001 Topical Rosacea Agents | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.90.002 Tazarotene | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.90.003 Tretinoin | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.90.039 Topical Corticosteroids | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.90.040 Topical Antifungals and Antibiotics | 2025-12-12 |